AYURCANN HOLDINGS CORP. PROVIDES CORPORATE OVERVIEW
HOLDINGS CORP. PROVIDES CORPORATE OVERVIEW
Toronto, Ontario, Canada -- October 6, 2021 -- InvestorsHub
NewsWire -- Ayurcann Holdings Corp. (CSE: AYUR) (FSE: 3ZQ0) (the
"Company" or "Ayurcann"), would like to provide current and
prospective investors with a corporate overview on the Company and
Introduction to Ayurcann Holdings Corp.
Ayurcann is a cannabis extraction and white label product
manufacturing company focused on the Canadian market and strategic
partnerships with International Brands. Ayurcann offers turn-key
extraction, product formulation and manufacturing solutions in the
Cannabis Industry. The Company operates out of Pickering, Ontario,
within a close proximity to over 200 licensed cannabis producers
("LPs"), with annual capacity to process 200,000 kg of biomass and
over 1m filling work.
- Seasoned management team led by 2 founders with strong
entrepreneurial backgrounds who have run multiple profitable
businesses in a variety of industries to successful exits.
- Granted an R&D license in August 2019 to start formulation
and IP development concentrating on high potency recreational and
medicinal THC and CBD products.
- Granted a Standard Processor License in January 2020 and
offering scalable white label production and toll processing
solutions to Canadian LPs and international cannabis brands.
- Granted an Amendment to the "Standard Processing Licence" to
allow for sales in January 2021.
- Fully built-out extraction and manufacturing facility with a
focus on high margin extract products in Cannabis 2.0 and 3.0.
- Current yearly capacity for co-packaging of over 1 million vape
and tincture filling.
- Expansion into Phase II offering the ability to broaden white
label manufacturing and fulfillment capabilities. Expended
extraction and processing capacity of up to 300,000 kg/year
- Debt FREE with substantial equity ownership by management and
- Over $2,500,000 in revenue the last quarter and over $1,000,000
in positive adjusted EBITDA
Ayurcann believes that it is targeting an underserved market, which
is currently dominated by a handful of larger unprofitable Ayurcann
believes that this leaves a great opportunity for a flexible and
profitable company to gain market share and service small and
mid-sized companies that do not have in-house extraction,
manufacturing, or product formulation capabilities. Ayurcann has
secured orders with both publicly listed Canadian and international
To learn more on the Company, please visit www.Ayurcann.com, and the Company's SEDAR
profile at www.sedar.com.
For further information, please contact:
Igal Sudman, Chairman, Chief Executive Officer and Corporate
Ayurcann Holdings Corp.
About Ayurcann Holdings Corp.:
Ayurcann is a leading post-harvest solution provider with a
focus on providing and creating custom processes and pharma grade
products for the adult use and medical cannabis industry in Canada.
Ayurcann is focused on becoming the partner of choice for leading
Canadian cannabis brands by providing best-in-class, proprietary
services including ethanol extraction, formulation, product
development and custom manufacturing.
Neither the Canadian Securities Exchange nor its Regulation
Services Provider have reviewed or accept responsibility for the
adequacy or accuracy of this release.
Certain statements included in this press release constitute
forward-looking information or statements (collectively,
"forward-looking statements"), including those identified by the
expressions "anticipate", "believe", "plan", "estimate", "expect",
"intend", "may", "should" and similar expressions to the extent
they relate to the Company or its management. The forward- looking
statements are not historical facts but reflect current
expectations regarding future results or events. This press release
contains forward looking statements, including but not limited to
statements relating to the Company's expansion plans and future
production capacity. These forward-looking statements are based on
current expectations and various estimates, factors and assumptions
and involve known and unknown risks, uncertainties and other
Forward-looking statements are not guarantees of future
performance and involve risks, uncertainties and assumptions which
are difficult to predict. Factors that could cause the actual
results to differ materially from those in forward-looking
statements include, but are not limited to, failure to obtain
regulatory approval, ability to increase production at the
Company's facilities, the continued availability of capital and
financing, and general economic, market or business conditions.
Forward-looking statements contained in this press release are
expressly qualified by this cautionary statement. These statements
should not be read as guarantees of future performance or results.
Such statements involve known and unknown risks, uncertainties and
other factors that may cause actual results, performance or
achievements to be materially different from those implied by such
statements. Although such statements are based on management's
reasonable assumptions, there can be no assurance that the
statements will prove to be accurate or that management's
expectations or estimates of future developments, circumstances or
results will materialize. Although the Company has attempted to
identify important risks, uncertainties and factors which could
cause actual results to differ materially, Further, there may be
others that cause results not to be as anticipated, estimated or
intended and such changes could be material. Public health
crises, including the ongoing novel coronavirus (COVID-19)
pandemic, could have significant economic and geopolitical impacts
that may adversely affect the Company's business, financial
condition and/or results of operations. The Company
assumes no responsibility to update or revise forward-looking
information to reflect new events or circumstances unless required
by law. Readers should not place undue reliance on the Company's
Historical Stock Chart
From Jun 2022 to Jul 2022
Historical Stock Chart
From Jul 2021 to Jul 2022